Page 6 - Markus Hoffmann News Today

More attention needed to prevent barnacle fouling in ship niche areas, says I-Tech Research commissioned by Swedish biotechnology company, I-Tech AB has confirmed that barnacle fouling is hugely prevalent in ship niche areas and that the industry needs to take steps to mitigate the impact of hard fouling in these areas. In 2020, I-Tech AB commissioned UK based marine coatings consultants, to analyse the hull condition of a 249-ship sample in dry dock spanning four years between 2015-19. As well...

 E-Mail It has been known for about a year that minks can become infected with SARS-CoV-2. The virus had been transmitted from humans to farmed mink and mutated in infected animals. Mutations were acquired in the spike protein, which is crucial for the entry of the virus into host cells and represents the central point of attack for antibodies. These SARS-CoV-2 variants from mink were transmitted back to humans, raising concerns that minks could be a continuing source of infection of humans wi...

Pancreatitis drug blocks SARS-CoV-2 activators in the upper respiratory tract Pancreatitis drug Camostat inhibits new SARS-CoV-2 activators identified in the upper respiratory tract. There are no therapeutics available that have been developed for COVID-19 treatment. Repurposing already available medication for COVID-19 therapy is an attractive option to shorten the road to treatment development. The drug Camostat could be suitable. Camostat exerts antiviral activity by blocking the protease TM...

Biomass-balanced material makes COVID vaccine distribution a green effort 3 March 2021 × Thermocon vaccine boxes made from Styropor BMB have an improved environmental profile Under the name Thermocon, Schaumaplast develops and produces passive (non-electric) cooling systems for the pharmaceutical industry. The lightweight thermal boxes can be fitted with special cooling elements for almost any temperature range and for different volumes. This flexibility — in terms of siz...

Quantum Computing: Boehringer Ingelheim and Google Partner for Pharma R&D ● Quantum computing offers the potential to significantly accelerate and optimize the discovery of future new medicines for patients ● Scientists from both companies will be breaking new ground in the application of quantum computing to molecular dynamics simulations ● Boehringer Ingelheim has set up a dedicated Quantum Lab with leading experts Boehringer Ingelheim announced today a collaborative agreement with Goo...